Desktop Site
|
25 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
74,339.44
+486.50
+0.66 %
Corporate Announcement
Security Code
500420
Company
TORRENT PHARMACEUTICALS LTD.
Exchange Disseminated Time
Board to consider Q3 results & Interim Dividend on January 30, 2019 |
01/11/19 17:02
Torrent Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on January 30, 2019, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2018.
In the above meeting, the Board would also consider the following:
i. Payment of Interim Dividend for the year 2018-19.
ii. Issue of Unsecured / Secured Redeemable Non-Convertible Debentures / Bonds by way of private placement.
iii. Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes.
If such issue of Equity shares is approved by the Board of Directors, Shareholders' approval will be taken through postal ballot.
As per the provisions of the Code of Conduct to Regulate, Monitor and Report Trading by Insiders of the Company, the trading window shall been closed from January 16, 2019 to February 01, 2019.
<< Back
Recently Viewed